Research
RESEARCH STRATEGY
Stemedica is dedicated to conducting pre-clinical and clinical research for medical conditions and diseases where there are currently no effective treatment alternatives. The Company focuses its research efforts on developing stem cells for three main therapeutic areas: neurodegeneration, diseases of the eye and wound care including ulcers, scars and burns.
Stemedica USA is focused on an FDA pathway which includes pre-clinical and Investigational New Drug ("IND") submission for the treatment of stroke, traumatic brain injury and wound care. On-going pre-clinical studies at several institutions are being conducted and are soon to be followed by applications for clinical trials in the United States and other locations around the world.
Stemedica International is focused on providing multiple stem cell formulations to accredited hospitals and research institutions outside of the United States that are in the process of conducting pre-clinical and clinical studies for neurodegenerative diseases and conditions as well as diseases of the eye.
For more information on pre-clinical studies being conducted in the United
States and in other locations around the world, please refer to the Research
Collaborators Section of this website.